Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Abnormalities and CYP2C19[original query] |
---|
CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication. Blood 2003 Apr 101 (7): 2770-4. Bowen David T, Frew Marion E, Rollinson Sara, Roddam Philippa L, Dring Ann, Smith Martyn T, Langabeer Stephen E, Morgan Gareth |
Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes. International journal of antimicrobial agents 2009 Jul 34 (1): 91-4. Matsumoto Kazuaki, Ikawa Kazuro, Abematsu Kazuko, Fukunaga Naoko, Nishida Kentaro, Fukamizu Tomohide, Shimodozono Yoshihiro, Morikawa Norifumi, Takeda Yasuo, Yamada Katsus |
Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy. International journal of cardiology 2017 Feb 229 113-118. Tantray Javeed Ahmad, Reddy K Pratap, Jamil Kaiser, Kumar Y Shi |
CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma. Experimental oncology 2021 12 43 (4): 336-340. Kostiukova N I, Fishchuk L Ye, Rossokha Z I, Medvedieva N L, Andreieva S V, Bloshchinska S V, Popova O F, Vydyborets S V, Gorovenko N |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: